Cite
APA Citation
Furie, R., Werth, V., Merola, J., Reynolds, T., Stevenson, L., Wang, W., Smirnakis, K., Barbey, C., Musselli, C., Werneburg, B., Rabah, D., & Franchimont, N. (n.d.). sAT0222 BIIB059, a monoclonal antibody targeting BDCA2, shows evidence of biological activity and early clinical proof of concept in subjects with active cutaneous le. Annals of the rheumatic diseases, 76, 857. http://access.bl.uk/ark:/81055/vdc_100135166772.0x000059